We are live on ! Find out more
AA

AlphaMark Advisors Portfolio holdings

AUM $231M
1-Year Est. Return 19.98%
This Fund
S&P 500
This Quarter Est. Return
+6.81%
1 Year Est. Return
+19.98%
3 Year Est. Return
+26.38%
5 Year Est. Return
+72.27%
10 Year Est. Return
+180.76%
AUM
$239M
AUM Growth
+$8.32M
Cap. Flow
-$5.16M
Cap. Flow %
-2.16%
Top 10 Hldgs %
35.11%
Holding
546
New
36
Increased
93
Reduced
108
Closed
33

Top Buys

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$3.15M
2
BMY icon
Bristol-Myers Squibb
BMY
+$2.48M
3
DLTR icon
Dollar Tree
DLTR
+$1.94M
4
VTV icon
Vanguard Morningstar Value ETF
VTV
+$857K
5
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$833K

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$4.4M
2
EOG icon
EOG Resources
EOG
+$2.91M
3
UTHR icon
United Therapeutics
UTHR
+$2.5M
4
ZBRA icon
Zebra Technologies
ZBRA
+$1.98M
5
PVH icon
PVH
PVH
+$1.43M

Sector Composition

Rank Sector Weight
1 Miscellaneous 44.8%
2 Financials 10.55%
3 Healthcare 7.46%
4 Consumer Staples 7.28%
5 Technology 6.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMAT icon
251
Applied Materials
AMAT
$330B
$24K 0.01%
400
– –
PBCT
252
DELISTED
People's United Financial Inc
PBCT
$24K 0.01%
+1,400
New +$22.9K
BSX icon
253
Boston Scientific
BSX
$63.6B
$23K 0.01%
500
– –
PEY icon
254
Invesco High Yield Equity Dividend Achievers ETF
PEY
$1.11B
$23K 0.01%
1,225
– –
STE icon
255
Steris
STE
$20.5B
$23K 0.01%
150
– –
VO icon
256
Vanguard Morningstar Mid-Cap ETF
VO
$104B
$23K 0.01%
512
– –
XLE icon
257
State Street Energy Select Sector SPDR ETF
XLE
$42B
$23K 0.01%
754
– –
TVRD
258
Tvardi Therapeutics
TVRD
$23.1M
$23K 0.01%
40
-1
-2% -$702
IEMG icon
259
iShares Core MSCI Emerging Markets ETF
IEMG
$158B
$22K 0.01%
410
– –
RTX icon
260
RTX Corp
RTX
$265B
$22K 0.01%
238
– –
USRT icon
261
iShares Core US REIT ETF
USRT
$4.35B
$22K 0.01%
400
– –
NTES icon
262
NetEase
NTES
$75.4B
$21K 0.01%
350
– –
WPM icon
263
Wheaton Precious Metals
WPM
$66.6B
$21K 0.01%
700
– –
FDL icon
264
First Trust Morningstar Dividend Leaders Index Fund
FDL
$7.9B
$20K 0.01%
+625
New +$19.9K
HBAN icon
265
Huntington Bancshares
HBAN
$32B
$20K 0.01%
1,349
– –
ICLR icon
266
Icon
ICLR
$13.4B
$20K 0.01%
115
-5
-4% -$771
MS icon
267
Morgan Stanley
MS
$318B
$20K 0.01%
+400
New +$18.9K
V icon
268
Visa
V
$693B
$20K 0.01%
109
– –
XPO icon
269
XPO
XPO
$20.4B
$20K 0.01%
734
– –
BAC icon
270
Bank of America
BAC
$405B
$19K 0.01%
534
+2
+0.4% +$65
EWG icon
271
iShares MSCI Germany ETF
EWG
$1.68B
$19K 0.01%
650
-300
-32% -$8.56K
RITM icon
272
Rithm Capital
RITM
$5.29B
$19K 0.01%
1,160
– –
ACN icon
273
Accenture
ACN
$116B
$18K 0.01%
86
– –
DAL icon
274
Delta Air Lines
DAL
$51.2B
$18K 0.01%
301
– –
IGE icon
275
iShares North American Natural Resources ETF
IGE
$783M
$18K 0.01%
600
– –
9 10
11
12 13

Similar funds

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
MWS
Maxwell Wealth Strategies Pleasanton, California $245M AUM 23.39% 1-Year Est. Return
LHR
Lunate Holding RSC Al Maryah Island, Abu Dhabi, United Arab Emirates $211M AUM
HPFG
Hart & Patterson Financial Group Amherst, Massachusetts $206M AUM 7.82% 1-Year Est. Return
GWM
Gray Wealth Management Bangor, Maine $264M AUM 19.5% 1-Year Est. Return
KC
Kades & Cheifetz Berwyn, Pennsylvania $195M AUM 11.87% 1-Year Est. Return
SL
SIB LLC New York, New York $190M AUM 9.27% 1-Year Est. Return
CSWM
Cassady Schiller Wealth Management Cincinnati, Ohio $273M AUM 17.91% 1-Year Est. Return

AlphaMark Advisors's Q4 2019 Portfolio in Review

As of Q4 2019, AlphaMark Advisors held 546 positions worth $239M, up 3.6% from $231M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

AlphaMark Advisors's Q4 2019 filing shows 36 new, 93 increased, 108 reduced and 33 closed positions. Its largest new stake was Alexion Pharmaceuticals: 29,481 shares worth $3.19M. The largest sale was Celgene Corp, an estimated $4.4M.

By sector, the portfolio is most concentrated in Miscellaneous at 45% of assets, up from 43% a quarter earlier, followed by Financials and Healthcare.

  • AlphaMark Advisors's largest Q4 2019 buy was Alexion Pharmaceuticals: 29,481 shares worth $3.19M.
  • AlphaMark Advisors added most to Bristol-Myers Squibb in Q4 2019, an estimated $2.48M increase.
  • AlphaMark Advisors's biggest Q4 2019 reduction was EOG Resources, cutting an estimated $2.91M.
  • AlphaMark Advisors fully exited Celgene Corp in Q4 2019, selling an estimated $4.4M.
  • AlphaMark Advisors's ten largest holdings make up 35% of its $239M portfolio in Q4 2019.
  • AlphaMark Advisors opened 36 new positions and closed 33 in Q4 2019.
  • AlphaMark Advisors's portfolio value rose 3.6% quarter-over-quarter to $239M.

Based on AlphaMark Advisors's 13F filing for Q4 2019, filed 7 Feb 2020.